SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-23-018812
Filing Date
2023-04-18
Accepted
2023-04-18 08:50:32
Documents
6
Period of Report
2023-06-21

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20007004x1_pre14a.htm PRE 14A 1132694
2 logo_aquestive-reg.jpg GRAPHIC 43389
3 logo_aquestive-regx1.jpg GRAPHIC 54294
4 ny20007004x1_pc01.jpg GRAPHIC 620354
5 ny20007004x1_pc02.jpg GRAPHIC 577831
6 sig_lorijbraender.jpg GRAPHIC 26060
  Complete submission text file 0001140361-23-018812.txt   2953413
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38599 | Film No.: 23825592
SIC: 2834 Pharmaceutical Preparations